The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study
Open accessAbstract
OBJECTIVES: Very few studies have investigated clinical features associated with treatment-resistant depression (TRD) defined as failure of at least 2 consecutive antidepressant trials. The primary objective of this multicenter study was to identify specific clinical and demographic factors associated with TRD in a large sample of patients with major depressive episodes that failed to reach response or remission after at least 2 consecutive adequate antidepressant treatments. METHOD: A total of 702 patients with DSM-IV major depressive disorder, recruited from January 2000 to February 2004, were included in the analysis. Among them, 346 patients were considered as nonresistant. The remaining 356 patients were considered as resistant, with a 17-item Hamilton Rating Scale for Depression score remaining greater than or equal to 17 after 2 consecutive adequate antidepressant trials. Cox regression models were used to examine the association between individual clinical variables and TRD. RESULTS: Among the clinical features investigated, 11 variables were found to be associated with TRD. We found anxiety comorbidity (p < .001, odds ratio [OR] = 2.6), comorbid panic disorder (p < .001, OR = 3.2) and social phobia (p = .008, OR = 2.1), personality disorder (p = .049, OR = 1.7), suicidal risk (p = .001, OR = 2.2), severity (p = .001, OR = 1.7), melancholia (p = .018, OR = 1.5), a number of hospitalizations > 1 (p = .003, OR = 1.6), recurrent episodes (p = .009, OR = 1.5), early age at onset (p = .009, OR = 2.0), and nonresponse to the first antidepressant received lifetime (p = .019, OR = 1.6) to be the factors associated with TRD. CONCLUSIONS: Our findings provide a set of 11 relevant clinical variables associated with treatment resistance in major depressive disorder that can be explored at the clinical level. The statistical model used in this analysis allowed for a hierarchy of these variables (based on the OR) showing that comorbid anxiety disorder is the most powerful clinical factor associated with TRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prevalence estimates of TRS, TRD, and treatment resistant OCD vary from 20-60% of the population with the condition. 26, 35–40”
From Treatment resistance in psychiatry: state of the art and new directions (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This comorbidity pattern may also affect treatment outcomes, with pharmacotherapy studies indicating that comorbid SAD is associated with a poorer course of illness (Mulder, Joyce, Frampton, Luty, & Sullivan, 2006), treatment-resistant depression (Souery et al., 2007), and a greater number and earlier onset of depressive recurrences compared with patients without comorbid SAD (Holma, Holma, Melart”
From An Integrated, Acceptance-Based Behavioral Approach for Depression With Social Anxiety: Preliminary Results (2014) · cites this paper as Souery et al., 2007
In the citing paper
“Timing may add heterogeneous features: certain individuals may change readily with respect to certain symptoms, whereas other subjects may have opposite tendencies [41].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [41]
In the citing paper
“The basic flaw is to assume improvement to be a unitary phenomenon [41].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [41]
In the citing paper
“Comorbidities such as substance use disorder can undermine previously effective maintenance therapy [18]”
In the citing paper
“Approximately only one in two patients with major depressive disorder (MDD) respond to their antidepressant treatment ( Rush et al., 2006 , Souery et al., 2007 , Thomas et al., 2013 )”
From Self-blame-selective hyper-connectivity between anterior temporal and subgenual cortices predicts prognosis in major depressive disorder (2023) · cites this paper as Souery et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83296-8 · Cited by 3,513
Self-citationSheehan, D., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller, E., Keskiner, A., Schinka, J., Knapp, E., Sheehan, M., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83297-x · Cited by 2,149
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
(1997) · PubMed · Cited by 727
Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
Treatment resistant depression: methodological overview and operational criteria
Souery, D., Amsterdam, J. D., de Montigny, C., Lecrubier, Y., Montgomery, S., Lipp, O., Racagni, G., Zohar, J., & Mendlewicz, J. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00004-2 · Cited by 443
Self-citation
Research works printed but not linked: 1
- a Copyright Daniel Souery, M.D. early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2004;55:875-881
Cited by
Sorted by citations
Items 201–300 of 526
Nonremission and time to remission among remitters in major depressive disorder: Revisiting STAR*D
Mojtabai, R. (2017) · Depression and Anxiety · doi:10.1002/da.22677 · Cited by 29
Dougherty, R. F., Clarke, P., Atli, M., Kuc, J., Schlosser, D. A., Dunlop, B. W., Hellerstein, D. J., Aaronson, S. T., Zisook, S., Young, A. H., et al. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06432-5 · Cited by 29
Authentic Self and Last Resort: International Perceptions of Psychiatric Neurosurgery
Cabrera, L. Y., Courchesne, C., Bittlinger, M., Müller, S., Martínez, R., Racine, É., & Illes, J. (2020) · Culture Medicine and Psychiatry · doi:10.1007/s11013-020-09679-1 · Cited by 28
Patrick, R. E., Dickinson, R. A., Gentry, M. T., Kim, J. U., Oberlin, L. E., Park, S., Principe, J. L., Teixeira, A. L., & Weisenbach, S. L. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.017 · Cited by 27
van Noorden, M. S., van Fenema, E. M., van der Wee, N. J. A., van Rood, Y. R., Carlier, I. V. E., Zitman, F. G., & Giltay, E. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.051 · Cited by 27
Ballenger, J. C. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79088-1 · Cited by 27
Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Dold, M., Swoboda, M. M. M., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01368-3 · Cited by 26
Self-citationThe neural markers of MRI to differentiate depression and panic disorder
Lai, C. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.013 · Cited by 26
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression
Mendlewicz, J., Crisafulli, C., Calati, R., Kocabaş, N. A., Massat, I., Linotte, S., Kasper, S. F., Fink, M., Sidoti, A., Scantamburlo, G., et al. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.063 · Cited by 25
Self-citationVagus Nerve Stimulation in Treatment-Resistant Depression: A Case Series of Long-Term Follow-up
Pigato, G., Rosson, S., Bresolin, N., Toffanin, T., Sambataro, F., Olivo, D., Perini, G., Causin, F., Denaro, L., Landi, A., et al. (2022) · Journal of Ect · doi:10.1097/yct.0000000000000869 · Cited by 25
Preclinical models of treatment-resistant depression: challenges and perspectives
Kolasa, M., & Faron‐Górecka, A. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00542-9 · Cited by 25
Simon, M. S., Burger, B., Weidinger, E., Arteaga-Henríquez, G., Zill, P., Musil, R., Drexhage, H. A., & Müller, N. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.615261 · Cited by 25
Advances in the Management of Treatment-Resistant Depression
Holtzheimer, P. E. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.4.foc488 · Cited by 25
Taipale, H. T., Reutfors, J., Tanskanen, A. J., Brandt, L., Tiihonen, J., DiBernardo, A., Mittendorfer‐Rutz, E., & Brenner, P. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02642-9 · Cited by 24
Excess deaths in treatment-resistant depression
Brenner, P., Reutfors, J., Nijs, M., & Andersson, T. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211006508 · Cited by 24
Serretti, A., Chiesa, A., Crisafulli, C., Massat, I., Linotte, S., Calati, R., Kasper, S. F., Bailer, U. F., Lecrubier, Y., Fink, M., et al. (2012) · Neuropsychobiology · doi:10.1159/000329553 · Cited by 24
Self-citationPredictors of Poor Response to Depression Treatment in Primary Care
Rossom, R. C., Solberg, L. I., Vazquez‐Benitez, G., Whitebird, R. R., Crain, A. L., Beck, A. L., & Unützer, J. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201400285 · Cited by 24
Efficacy of venlafaxine extended release in major depressive disorder patients
Lyndon, G. J., Prieto, R., Wajsbrot, D., Allgulander, C., & Bandelow, B. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000256 · Cited by 24
Epidemiology of treatment resistant depression among major depressive disorder patients in Israel
Sharman Moser, S., Chodick, G., Gelerstein, S., Barit Ben David, N., Shalev, V., & Stein-Reisner, O. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04184-8 · Cited by 23
The complexity of treatment-resistant depression: A data-driven approach
Rost, F., Booker, T., Gonsard, A., de Felice, G., Asseburg, L., Castillo, J. M., Koutoufa, I., Ridsdale, H., Johnson, R., Taylor, D., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.093 · Cited by 23
Kato, M., Serretti, A., Nonen, S., Takekita, Y., Wakeno, M., Azuma, J., & Kinoshita, T. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.6 · Cited by 23
Self-citationNúñez, N. A., Comai, S., Dumitrescu, E., Ghabrash, M. F., Tabaka, J. M., Saint-Laurent, M., Vida, S., Kolivakis, T., Fielding, A., Low, N. C. P., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1641-y · Cited by 23
Petersen, T., Andreotti, C., Chelminski, I., Young, D., & Zimmerman, M. A. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.036 · Cited by 23
Muhonen, L. H., Lönnqvist, J. K., Lahti, J. M. T., & Alho, H. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.05.001 · Cited by 23
Dalrymple, K. L., Morgan, T. A., Lipschitz, J. M., Martinez, J. H., Tepe, E., & Zimmerman, M. (2014) · Behavior Modification · doi:10.1177/0145445513518422 · Cited by 22
“…that comorbid SAD is associated with a poorer course of illness (Mulder, Joyce, Frampton, Luty, & Sullivan, 2006), treatment-resistant depression (Souery et al., 2007), and a greater number and earlier onset of depressive recurrences compared with patients without comorbid SAD (Holma, Holma,…”
BackgroundGenetics-informed precision treatment formulation in schizophrenia and bipolar disorder
Reay, W. R., Geaghan, M. P., Atkins, J., Carr, V. J., Green, M. J., & Cairns, M. J. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.07.011 · Cited by 22
Yrondi, A., Javelot, H., Nobile, B., Boudieu, L., Aouizerate, B., Llorca, P., Charpeaud, T., Bennabi, D., Antoine Lefrere, A., & Samalin, L. (2024) · L Encéphale · doi:10.1016/j.encep.2023.11.029 · Cited by 22
Adamczyk, M., Gazea, M., Wollweber, B., Holsboer, F., Dresler, M., Steiger, A., & Pawlowski, M. A. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.007 · Cited by 22
Phenomenology of psychotic mood disorders: Lifetime and major depressive episode features
Buckley, P. F. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.07.043 · Cited by 22
Kato, M., Takekita, Y., Koshikawa, Y., Sakai, S., Bandou, H., Nishida, K., Sunada, N., Onohara, A., Hatashita, Y., Serretti, A., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.02.003 · Cited by 22
Self-citationDold, M., Bartova, L., Kautzky, A., Souery, D., Mendlewicz, J., Serretti, A., Porcelli, S., Zohar, J., Montgomery, S., & Kasper, S. F. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.05.004 · Cited by 22
Self-citationMicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action
Oved, K., Farberov, L., Gilam, A., Israel‐Elgali, I., Haguel, D., Gurwitz, D., & Shomron, N. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00355 · Cited by 22
Dold, M., Bartova, L., Fugger, G., Mitschek, M. M. M., Kautzky, A., Frey, R., Montgomery, S., Zohar, J., Mendlewicz, J., Souery, D., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.636 · Cited by 22
Self-citationA clinically useful social anxiety disorder outcome scale
Dalrymple, K. L., Martinez, J. H., Tepe, E., Young, D., Chelminski, I., Morgan, T. A., & Zimmerman, M. A. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.02.006 · Cited by 22
Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy
Winkler, D., Pjrek, E., Lanzenberger, R., Baldinger, P., Eitel, D., Kasper, S., & Frey, R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.06.006 · Cited by 21
Self-citationCombining inflammatory miRNA molecules as diagnostic biomarkers for depression: a clinical study
Brás, J. P., Pinto, S., von Doellinger, O., Prata, J., Coelho, R. C., Barbosa, M. A., Almeida, M. I., & Santos, S. G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1227618 · Cited by 21
Dold, M., Bartova, L., Kautzky, A., Serretti, A., Porcelli, S., Souery, D., Mendlewicz, J., Montgomery, S., Zohar, J., & Kasper, S. F. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.10.003 · Cited by 21
Self-citationShin, C., Jeon, S. W., Lee, S., Pae, C., Hong, N., Lim, H. K., Patkar, A. A., Masand, P. S., An, H., & Han, C. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2023.21.1.135 · Cited by 21
Höfer, P., Schosser, A., Calati, R., Serretti, A., Massat, I., Kocabaş, N. A., Konstantinidis, A., Linotte, S., Mendlewicz, J., Souery, D., et al. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0375-y · Cited by 21
Self-citationClinical predictors of treatment resistant depression
Serretti, A., Kasper, S. F., Bartova, L., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P. P., Rujescu, D., Kautzky, A., Attanasio, F., et al. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.06.011 · Cited by 20
Self-citationBlood transcriptional response to treatment-resistant depression during electroconvulsive therapy
Israel‐Elgali, I., Hertzberg, L., Shapira, G., Segev, A., Krieger, I., Nitzan, U., Bloch, Y., Pillar, N., Mayer, O., Weizman, A., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.039 · Cited by 20
Svensson, M., Brundin, L., Erhardt, S., Madaj, Z., Hållmarker, U., James, S. K., & Deierborg, T. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112546 · Cited by 20
Victor, M. M., Grevet, E. H., Salgado, C. A. I., Silva, K. L., Sousa, N. O., Karam, R. G., Vitola, E. S., Picon, F. A., Zeni, G. D., Contini, V., et al. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c00b1e · Cited by 20
Elsaesser, M., Herpertz, S., Piosczyk, H., Jenkner, C., Hautzinger, M., & Schramm, E. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057672 · Cited by 19
Fornaro, M., Fusco, A., Novello, S., Mosca, P., Anastasia, A., Blasio, A. D., Iasevoli, F., & de Bartolomeis, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00438 · Cited by 19
Chang, J. S., Moon, E., Cha, B., & Ha, K. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.020 · Cited by 19
van Krugten, F. C. W., Kaddouri, M., Goorden, M., van Balkom, A. J. L. M., Bockting, C., Peeters, F. P. M. L., & Roijen, L. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171659 · Cited by 19
Bareš, M., Novák, T., Vlček, P., Hejzlar, M., & Brunovský, M. (2019) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2019.06.006 · Cited by 19
Mncube, K., Möller, M., & Harvey, B. H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.688150 · Cited by 19
Souery, D., Calati, R., Papageorgiou, K., Juven‐Wetzler, A., Gailledreau, J., Modavi, D., Sentissi, O., Pitchot, W., Papadimitriou, G. N., Dikeos, D. G., et al. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.987814 · Cited by 19
Self-citationVariation in the HTR1A and HTR2A genes and social adjustment in depressed patients
Antypa, N., Calati, R., Souery, D., Pellegrini, S., Sentissi, O., Amital, D., Moser, U., Montgomery, S., Kasper, S. F., Zohar, J., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.036 · Cited by 19
Self-citationLee, D. Y., Kim, N., Park, C., Gan, S., Son, S. J., Park, R. W., & Park, B. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115817 · Cited by 18
Susceptibility to Treatment-Resistant Depression Within Families
Cheng, C., Chen, M., Tsai, S., Chang, W.-H., Tsai, C.-F., Lin, W., Bai, Y., Su, T., Chen, T., & Li, C. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.0378 · Cited by 18
Chen, L.-C., Chen, M., Bai, Y., Chen, T.-J., & Su, T. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000574 · Cited by 18
Targeting Treatment-Resistant Depression
Mathys, M. L., & Mitchell, B. G. (2011) · Journal of Pharmacy Practice · doi:10.1177/0897190011426972 · Cited by 18
Yrondi, A., Bennabi, D., Haffen, É., Garnier, M., Bellivier, F., Bourgerol, T., Camus, V., d’Amato, T., Doumy, O., Haesebaert, F., et al. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00244 · Cited by 18
Kharasch, E. D., Neiner, A., Kraus, K., Blood, J., Stevens, A., Schweiger, J. A., Miller, J. P., & Lenze, E. J. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1309 · Cited by 18
Mogi, T., & Yoshino, A. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.02.005 · Cited by 17
Zaninotto, L., Souery, D., Calati, R., Camardese, G., Janiri, L., Montgomery, S., Kasper, S. F., Zohar, J., Ronchi, D. D., Mendlewicz, J., et al. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.1.48 · Cited by 17
Self-citationCause-specific mortality in treatment-resistant major depression: Population-based cohort study
Gustafsson, T. T., Taipale, H. T., Lähteenvuo, M., Tanskanen, A., Svirskis, T., Huoponen, S., & Tiihonen (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.064 · Cited by 16
Lai, C. (2014) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12090230 · Cited by 16
Chae, W. R., Nagel, J. M., Kuehl, L. K., Gold, S. M., Wingenfeld, K., & Otte, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.044 · Cited by 16
Bareš, M., Brunovský, M., Stopková, P., Hejzlar, M., & Novák, T. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s226577 · Cited by 16
Dumitriu, D., Collins, K., Alterman, R. L., & Mathew, S. J. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20044 · Cited by 16
Bolu, A., Gündoğmuş, İ., Aydın, M. S., Fadıloğlu, D., Erken, Y., & Uzun, Ö. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113986 · Cited by 15
Habra, M. E., Baker, B., Frasure‐Smith, N., Swenson, J. R., Koszycki, D., Butler, G. S., van Zyl, L. T., & Lespérance, F. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.02.010 · Cited by 15
Liao, L., Wu, Z., Mellor, D. J., Peng, D., Zhang, C., Xu, J., Wang, C., Cui, L., & Fang, Y. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.005 · Cited by 15
Griffiths, C., O’Neill-Kerr, A., Millward, T., & da Silva, K. M. (2019) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2018.1562077 · Cited by 15
Papakostas, G. I., D, M. F. M., Freeman, M. P., Shelton, R. C., Thase, M. E., Jha, M. K., Trivedi, M. H., Dirks, B., Liu, K., & Stankovic, S. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000328 · Cited by 15
Treatment‐resistant Depression
Möller, H., Seemüller, F., Schennach, R., & Gupta, R. K. (2013) · Wiley eBooks · doi:10.1002/9781118556719.ch2 · Cited by 15
Jensen, K. J., Gronemann, F. H., Ankarfeldt, M. Z., Jimenez-Solem, E., Alulis, S., Riise, J., Bødker, N., Osler, M., & Petersen, J. (2022) · PLOS ONE · doi:10.1371/journal.pone.0275299 · Cited by 15
Rzeźniczek, S., Obuchowicz, M., Datka, W., Siwek, M., Dudek, D., Kmiotek‐Wasylewska, K., Oved, K., Shomron, N., Gurwitz, D., & Pilc, A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.90 · Cited by 14
Sforzini, L. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100331 · Cited by 14
Molecular Targets of Cannabinoids Associated with Depression
Paudel, P., Ross, S. A., & Li, X. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210623144658 · Cited by 14
Rafało-Ulińska, A., Pochwat, B., Misztak, P., Bugno, R., Kryczyk‐Poprawa, A., Opoka, W., Muszyńska, B., Poleszak, E., Nowak, G., & Szewczyk, B. (2022) · Nutrients · doi:10.3390/nu14132746 · Cited by 13
Major challenges in youth psychopathology: treatment-resistant depression. A narrative review
Menculini, G., Cinesi, G., Scopetta, F., Cardelli, M., Caramanico, G., Balducci, P. M., Giorgi, F. D., Moretti, P., & Tortorella, A. A. V. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1417977 · Cited by 13
Wong, S. M. Y., Leung, D. K. Y., Liu, T., Ng, Z. L. Y., Wong, G. H. Y., Chan, W. C., & Lum, T. Y. S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06281-2 · Cited by 13
Gill, K., Hett, D., Carlish, M., Amos, R., Khatibi, A., Morales‐Muñoz, I., & Marwaha, S. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.275 · Cited by 13
Junkes, L., Quagliato, L. A., Appolinário, J. C., Shader, R. I., & Nardi, A. E. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107876 · Cited by 13
Zhdanava, M., Kuvadia, H., Joshi, K., Daly, E., Pilon, D., Rossi, C., Morrison, L., Lefèbvre, P., & Nelson, C. J. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1844645 · Cited by 13
Gender Differences among Patients with a Single Depressive Episode
Bukh, J. D., Bock, C., Vinberg, M., Gether, U., & Kessing, L. V. (2010) · Psychopathology · doi:10.1159/000288638 · Cited by 13
Abas, M., Weiss, H. A., Simms, V. M., Verhey, R., Rusakaniko, S., Araya, R., & Chibanda, D. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100333 · Cited by 13
A Brief Version of the Leahy Emotional Schema Scale: a Validation Study
Suh, J.-W., Lee, H. J., Yoo, N., Min, H., Seo, D. G., & Choi, K. (2019) · International Journal of Cognitive Therapy · doi:10.1007/s41811-018-0039-4 · Cited by 13
Bortolon, C., & Raffard, S. (2019) · L Encéphale · doi:10.1016/j.encep.2019.06.001 · Cited by 13
Nasso, E. D., Chiesa, A., Serretti, A., Ronchi, D. D., & Mencacci, C. (2011) · Clinical Drug Investigation · doi:10.2165/11588800-000000000-00000 · Cited by 13
Self-citationMcArthur, R. A., & Borsini, F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00032-1 · Cited by 13
Orsini, L. S., O’Connor, S. J., Mohwinckel, M., Marwood, L., Pahwa, A., Bryder, M. N., Dong, X., & Levine, S. P. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2113692 · Cited by 12
Aboelbaha, S., Zolezzi, M., Abdallah, O., & Eltorki, Y. H. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s410240 · Cited by 12
Sleep-related breathing disturbances in adolescents with treatment resistant depression
Robillard, R., Chase, T. D., Courtney, D., Ward, M., Koninck, J. D., & Lee, E. K. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2018.12.010 · Cited by 12
Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care
Liberman, J. N., Davis, T., Pesa, J., Chow, W., Verbanac, J., Heverly-Fitt, S., & Ruetsch, C. R. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.8.987 · Cited by 12
Treating each and every depressed patient
Kennedy, S. H. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093270 · Cited by 12
Lin, C., Huang, C., & Chen, C. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx114 · Cited by 11
Griffiths, C., da Silva, K. M., Vai, R. D., & O’Neill-Kerr, A. (2019) · Open Journal of Depression · doi:10.4236/ojd.2019.81003 · Cited by 11
Studying treatment-effect heterogeneity in precision medicine through induced subgroups
Sies, A., Demyttenaere, K., & Mechelen, I. V. (2019) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2019.1579220 · Cited by 11
Self-citationThe cost-of-illness and burden-of-disease of treatment-resistant depression in Austria
Walter, E., Traunfellner, M., Gleitsmann, M., Zalesak, M., & Helmenstein, C. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2264718 · Cited by 11
Zaninotto, L., Souery, D., Calati, R., Sentissi, O., Kasper, S. F., Akimova, E., Zohar, J., Montgomery, S., Mendlewicz, J., & Serretti, A. (2013) · Annals of Clinical Psychiatry · doi:10.1177/104012371302500204 · Cited by 11
Self-citationSerretti, A., Souery, D., Antypa, N., Calati, R., Sentissi, O., Amital, D., Moser, U., Kasper, S. F., Zohar, J., & Mendlewicz, J. (2013) · Psychopathology · doi:10.1159/000345358 · Cited by 11
Self-citationA spectroscopic approach toward depression diagnosis: local metabolism meets functional connectivity
Demenescu, L. R., Colic, L., Li, M., Safron, A., Biswal, B., Metzger, C. D., Li, S., & Walter, M. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0726-1 · Cited by 11
Li, R., Wu, R., Chen, J., Kemp, D. E., Ren, M., Conroy, C. M., Chan, P., Serrano, M. B., Ganocy, S. J., Calabrese, J. R., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4339 · Cited by 11
Li, Q. S., Tian, C., McIntyre, M. H., Sun, Y., Hinds, D. A., & Narayan, V. A. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.06.011 · Cited by 11
Metadata
- Authors
- Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., Mendlewicz, J., & Group for the Study of Resistant Depression (GSRD)
- Affiliations
- Université Libre de Bruxelles (BE)
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-07-15
- Volume
- 68
- Issue
- 07
- Pages
- 1062-1070
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1969010498
- Cited by
- 521
- References
- 22
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 26 · 2023: 30 · 2022: 26 · 2021: 54 · 2020: 35 · 2019: 46 · 2018: 31 · 2017: 22 · 2016: 23 · 2015: 25 · 2014: 27 · 2013: 29 · 2012: 21
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Les Laboratories Pierre Fabre
- Fonds De La Recherche Scientifique - FNRS
- Servier
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, major depressive disorder, antidepressant non-response, anxiety comorbidity, panic disorder, social anxiety disorder, personality disorders, suicide risk, melancholia, depression severity, hospitalization, recurrent depression, age of onset, risk factors
- MeSH terms
- Adult, Aged, Antidepressive Agents, Mental Disorders, Major Depressive Disorder, Drug Resistance, Europe, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Recurrence, Comorbidity, Treatment Failure, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
